Research Article
Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
Figure 2
The CMT reduction of both groups had similar outcomes at all time points with no significant intergroup differences ().